Nucleolar repression facilitates initiation and maintenance of senescence

Cell Cycle

Volumn 14, Issue 22, 2015, Pages 3613-3623

  Yang, Leixiang ^a   Song, Tanjing ^a   Chen, Lihong ^a   Soliman, Hatem ^a   Chen, Jiandong ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Chemotherapy; Heterochromatin; NML; Nucleolus; P53; RDNA; Senescence

Indexed keywords

DNA DIRECTED RNA POLYMERASE; RIBOSOME DNA; RIBOSOME RNA; BAZ2A PROTEIN, HUMAN; E2F1 PROTEIN, HUMAN; HETEROCHROMATIN; HISTONE; METHYLTRANSFERASE; NONHISTONE PROTEIN; NUCLEAR PROTEIN; NUCLEOMETHYLIN PROTEIN, HUMAN; PROTEIN BINDING; SIRT1 PROTEIN, HUMAN; SIRTUIN 1; TRANSCRIPTION FACTOR E2F1;

ARTICLE; BREAST TUMOR; CANCER SURVIVAL; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME INHIBITION; GENE REPRESSION; GENETIC TRANSCRIPTION; HETEROCHROMATIN; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; SENESCENCE; STAINING; STIMULATION; APOPTOSIS; BLADDER TUMOR; CELL AGING; CELL CYCLE CHECKPOINT; CHEMISTRY; CHROMATIN ASSEMBLY AND DISASSEMBLY; FEMALE; GENETIC EPIGENESIS; GENETICS; MALE; METABOLISM; NUCLEOLUS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL AGING; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL NUCLEOLUS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA, RIBOSOMAL; E2F1 TRANSCRIPTION FACTOR; EPIGENESIS, GENETIC; FEMALE; HETEROCHROMATIN; HISTONES; HUMANS; MALE; METHYLTRANSFERASES; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA POLYMERASE I; RNA, RIBOSOMAL; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSCRIPTION, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 84953646060     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1100777     Document Type: Article

References (40)

1. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22; PMID:15734683; http://dx.doi.org/10.1016/j.cell.2005.02.003
2. d’Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nature Rev Cancer 2008; 8:512-22; http://dx.doi.org/10.1038/nrc2440
3. Schmitt CA. Cellular senescence and cancer treatment. Biochimica Et Biophysica Acta 2007; 1775:5-20; PMID:17027159
4. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192:547-56; PMID:21321098; http://dx.doi.org/10.1083/jcb.201009094
5. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479:232-6; PMID:22048312; http://dx.doi.org/10.1038/nature10600
6. Jackson JG, Pant V, Li Q, Chang LL, Quintas-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y, et al. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell 2012; 21:793-806; PMID:22698404; http://dx.doi.org/10.1016/j.ccr.2012.04.027
7. Wu PC, Wang Q, Grobman L, Chu E, Wu DY. Accelerated cellular senescence in solid tumor therapy. Exp Oncol 2012; 34:298-305; PMID:23070015
8. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109:335-46; PMID:12015983; http://dx.doi.org/10.1016/S0092-8674(02)00734-1
9. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-60; PMID:17251933; http://dx.doi.org/10.1038/nature05529
10. Roberson RS, Kussick SJ, Vallieres E, Chen SY, Wu DY. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res 2005; 65:2795-803; PMID:15805280; http://dx.doi.org/10.1158/0008-5472.CAN-04-1270
11. Mayer C, Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006; 25:6384-91; PMID:17041624; http://dx.doi.org/10.1038/sj.onc.1209883
12. McStay B, Grummt I. The epigenetics of rRNA genes: from molecular to chromosome biology. Ann Rev Cell Dev Biol 2008; 24:131-57; http://dx.doi.org/10.1146/annurev.cellbio.24.110707.175259
13. Zhai W, Comai L. Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol Cell Biol 2000; 20:5930-8; PMID:10913176; http://dx.doi.org/10.1128/MCB.20.16.5930-5938.2000
14. Voit R, Schafer K, Grummt I. Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol Cell Biol 1997; 17:4230-7; PMID:9234680
15. Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, Seite P. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. Oncogene 2006; 25:7577-86; PMID:16924243; http://dx.doi.org/10.1038/sj.onc.1209743
16. Drygin D, Lin A, Bliesath J, Ho CB, O’Brien SE, Proffitt C, Omori M, Haddach M, Schwaebe MK, Siddiqui-Jain A, et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res 2011; 71:1418-30; PMID:21159662; http://dx.doi.org/10.1158/0008-5472.CAN-10-1728
17. Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, Wall M, Cluse L, Drygin D, Anderes K, et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012; 22:51-65; PMID:22789538; http://dx.doi.org/10.1016/j.ccr.2012.05.019
18. Grummt I, Pikaard CS. Epigenetic silencing of RNA polymerase I transcription. Nat Rev Mol Cell Biol 2003; 4:641-9; PMID:12923526; http://dx.doi.org/10.1038/nrm1171
19. Santoro R, Li J, Grummt I. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet 2002; 32:393-6; PMID:12368916; http://dx.doi.org/10.1038/ng1010
20. Murayama A, Ohmori K, Fujimura A, Minami H, Yasuzawa-Tanaka K, Kuroda T, Oie S, Daitoku H, Okuwaki M, Nagata K, et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 2008; 133:627-39; PMID:18485871; http://dx.doi.org/10.1016/j.cell.2008.03.030
21. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rbmediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16; PMID:12809602; http://dx.doi.org/10.1016/S0092-8674(03)00401-X
22. Yang L, Song T, Chen L, Kabra N, Zheng H, Koomen J, Seto E, Chen J. Regulation of SirT1-Nucleomethylin Binding by rRNA Coordinates Ribosome Biogenesis with Nutrient Availability. Mol Cell Biol 2013; 33:3835-48; PMID:23897426; http://dx.doi.org/10.1128/MCB.00476-13
23. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22:4212-22; PMID:12912919; http://dx.doi.org/10.1093/emboj/cdg417
24. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606
25. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treatment 2010; 123:725-31; http://dx.doi.org/10.1007/s10549-009-0674-9
26. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol 2007; 8:574-85; PMID:17519961; http://dx.doi.org/10.1038/nrm2184
27. Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 2003; 22:6068-77; PMID:14609953; http://dx.doi.org/10.1093/emboj/cdg579
28. Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16:369-77; PMID:19878869; http://dx.doi.org/10.1016/j.ccr.2009.09.024
29. Colombo E, Alcalay M, Pelicci PG. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene 2011; 30:2595-609; PMID:21278791; http://dx.doi.org/10.1038/onc.2010.646
30. Guetg C, Lienemann P, Sirri V, Grummt I, Hernandez-Verdun D, Hottiger MO, Fussenegger M, Santoro R. The NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeats. EMBO J 2010; 29:2135-46; PMID:20168299; http://dx.doi.org/10.1038/emboj.2010.17
31. Wright WE, Shay JW. Cellular senescence as a tumorprotection mechanism: the essential role of counting. Curr Opin Genet Dev 2001; 11:98-103; PMID:11163158; http://dx.doi.org/10.1016/S0959-437X(00)00163-5
32. Angus SP, Solomon DA, Kuschel L, Hennigan RF, Knudsen ES. Retinoblastoma tumor suppressor: analyses of dynamic behavior in living cells reveal multiple modes of regulation. Mol Cell Biol 2003; 23:8172-88; PMID:14585976; http://dx.doi.org/10.1128/MCB.23.22.8172-8188.2003
33. Stark LA, Dunlop MG. Nucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosis. Mol Cell Biol 2005; 25:5985-6004; PMID:15988014; http://dx.doi.org/10.1128/MCB.25.14.5985-6004.2005
34. Vaughan S, Jat PS. Deciphering the role of nuclear factor-kappaB in cellular senescence. Aging 2011; 3:913-9; PMID:21990145
35. Keller C, Adaixo R, Stunnenberg R, Woolcock KJ, Hiller S, Buhler M. HP1(Swi6) Mediates the Recognition and Destruction of Heterochromatic RNA Transcripts. Mol Cell 2012; 47:215-27; PMID:22683269; http://dx.doi.org/10.1016/j.molcel.2012.05.009
36. Nemeth A, Conesa A, Santoyo-Lopez J, Medina I, Montaner D, Peterfia B, Solovei I, Cremer T, Dopazo J, Längst G. Initial genomics of the human nucleolus. PLoS Genet 2010; 6:e1000889; PMID:20361057; http://dx.doi.org/10.1371/journal.pgen.1000889
37. van Koningsbruggen S, Gierlinski M, Schofield P, Martin D, Barton GJ, Ariyurek Y, den Dunnen JT, Lamond AI. High-resolution whole-genome sequencing reveals that specific chromatin domains from most human chromosomes associate with nucleoli. Mol Biol Cell 2010; 21:3735-48; PMID:20826608; http://dx.doi.org/10.1091/mbc.E10-06-0508
38. Zhang LF, Huynh KD, Lee JT. Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell 2007; 129:693-706; PMID:17512404; http://dx.doi.org/10.1016/j.cell.2007.03.036
39. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62:1876-83; PMID:11912168
40. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007; 7:834-46; PMID:17957189; http://dx.doi.org/10.1038/nrc2256